Evidence map›Paper›PMID 29862066›Full record

ArticleJournal of ophthalmology2018

Continuation of Aspirin Therapy before Cataract Surgery with Different Incisions: Safe or Not?

Qingjian Li, Yiwen Qian, Yu Zhang, Gaoyuan Sun, Xian Zhou, Zhiliang Wang

Open access · goldAbstract read
In one paragraph

Article in Journal of ophthalmology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Qingjian Li *Department of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, China.
Yiwen Qian *Department of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, China.
Yu ZhangDepartment of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, China.
Gaoyuan SunDepartment of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, China.
Xian ZhouDepartment of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, China.
Zhiliang WangDepartment of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, China.ORCID 0000-0003-0944-8584
Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess whether to continue aspirin therapy while having uncomplicated phacoemulsification cataract surgery with different incisions.

methodsConsecutive patients having cataract surgery under topical anesthesia with different incisions between May 2016 and August 2017 were followed. 236 eyes of 166 patients on routine aspirin therapy were randomized into 2 groups: continuation group, 112 eyes; discontinuation group, 124 eyes. 121 eyes of 94 patients on no routine anticoagulant therapy were used as the control group. Patients were examined 1 day preoperatively and 1 day and 7 days postoperatively. Intraoperative and postoperative complications were recorded.

resultsStatistically, there was no significant difference about postoperative BCVA among three groups. A higher incidence of subconjunctival hemorrhage was shown in the continuation group than in the discontinuation group and the control group (17.0% versus 8.1%,

conclusionsThe outcomes indicated that phacoemulsification cataract surgery under topical anesthesia could be safely performed without ceasing systemic aspirin therapy. Clear corneal incision could be a better choice in patients treated with aspirin.

Identifiers

PMID29862066
PMCPMC5971353
OpenAlexW2800477788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.